UMIN ID: UMIN000016360
Registered date:28/01/2015
Study of Hyperthermic intraperitoneal chemotherapy(HIPEC) for peritoneal dissemination and appendiceal mucinous neoplasm
Basic Information
Recruitment status | Open public recruiting |
---|---|
Health condition(s) or Problem(s) studied | peritoneal dissemination and appendiceal mucinous neoplasm |
Date of first enrollment | 2014/06/20 |
Target sample size | 10 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Hyperthermic intraperitoneal chemotherapy |
Outcome(s)
Primary Outcome | Surgical factor(Blood loss, operative time, blood transfusion) ,and Perioperative factor(Complications, hospital stay, readmission rate after surgery) perioperative factor |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 79years-old |
Gender | Male and Female |
Include criteria | ・Patients with peritoneal metastasis of gastric cancer,colon cancer, or appendicecal mucosal neoplasm ・Patients with positive peritoneal cytology ・Except for cases having distant metastasis such as liver and lung, and cases having non-healing factor such as unresectable lymph node metastasis except for peritoneal metastasis |
Exclude criteria | ・Patients with heart disease(Arrhythmia requiring acute myocardial infarction within 6 months after the onset of ischemic heart disease, a medical treatment) ・Patients with a history of cerebrovascular disorder of cerebral infarction, cerebral hemorrhage, etc. ・Patients of systolic blood pressure less than 80mmHg or hypotension ・During pregnancy, Women suspected of being pregnant and Lactating woman ・Patients with dementia ・Patients with a history of shock during extracorporeal circulation therapy ・Patients taking stop angiotensin converting enzyme inhibitors, is difficult prior to extracorporeal circulation therapy ・Patients admitted unsuitable for the clinical study by research investigator |
Related Information
Primary Sponsor | Mie university gastrointestinal and pediatric surgery |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Mie University Hospital |
Secondary ID(s) |
Contact
public contact | |
Name | Masaki Ohi |
Address | 2-174 edobashi tsu city Japan |
Telephone | 059-232-1111 |
mohi@clin.medic.mie-u.ac.jp | |
Affiliation | Mie University Hospital Department of Innovative Surgery |
scientific contact | |
Name | Masaki Ohi |
Address | 2-174 edobashi tsu city Japan |
Telephone | 059-232-1111 |
mohi@clin.medic.mie-u.ac.jp | |
Affiliation | Mie University Hospital Department of Innovative Surgery |